<?xml version="1.0" encoding="UTF-8"?>
<ref id="B42-vaccines-07-00091">
 <label>42.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Weiss</surname>
    <given-names>I.D.</given-names>
   </name>
   <name>
    <surname>Wald</surname>
    <given-names>O.</given-names>
   </name>
   <name>
    <surname>Wald</surname>
    <given-names>H.</given-names>
   </name>
   <name>
    <surname>Beider</surname>
    <given-names>K.</given-names>
   </name>
   <name>
    <surname>Abraham</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Galun</surname>
    <given-names>E.</given-names>
   </name>
   <name>
    <surname>Nagler</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Peled</surname>
    <given-names>A.</given-names>
   </name>
  </person-group>
  <article-title>IFN-gamma treatment at early stages of influenza virus infection protects mice from death in a NK cell-dependent manner</article-title>
  <source>J. Interferon Cytokine Res. Off. J. Int. Soc. Interferon Cytokine Res.</source>
  <year>2010</year>
  <volume>30</volume>
  <fpage>439</fpage>
  <lpage>449</lpage>
  <pub-id pub-id-type="doi">10.1089/jir.2009.0084</pub-id>
 </element-citation>
</ref>
